Benefit of Hepatitis C Virus Core Antigen Assay in Prediction of Therapeutic Response to Interferon and Ribavirin Combination Therapy

M. Takahashi, H. Saito, M. Higashimoto, K. Atsukawa, H. Ishii
  • Journal of Clinical Microbiology, January 2005, ASM Journals
  • DOI: 10.1128/jcm.43.1.186-191.2005

The authors haven't yet claimed this publication.

Read Publication

In partnership with: